Who
Everett Cunningham
Director
Company insider
Files Form 4 as: Director, Arvinas; President and CEO, Quanterix; SVP, Chief Commercial Officer, Illumina; Chief Commercial Officer, Exact Sciences; SVP, Commercial, Quest Diagnostics.
In numbers
- Trades disclosed
- 124
- Buys
- 0
- Sells
- 15
- Bought
- $0
- Sold
- $22.7M
- Companies
- 5
- Companies where not an officer
- 1
- First trade
- 25 Feb 2013
- Last trade
- 24 Jun 2026
- Last filed
- 26 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 26 Jun 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —15,527 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,714 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,714 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —15,527 at $0.00 | filing |
| 19 Jan 2026filed 21 Jan 2026 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code A | —813,750 at $0.00 | filing |
| 19 Jan 2026filed 21 Jan 2026 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,070,000 at $0.00 | filing |
| 19 Jan 2026filed 21 Jan 2026 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code A | —813,750 at $0.00 | filing |
| 19 Jan 2026filed 21 Jan 2026 | QTRX Quanterixoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,070,000 at $0.00 | filing |
| 5 Jul 2025filed 8 Jul 2025 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $413K4,248 at $97.15 | filing |
| 25 Jun 2025filed 27 Jun 2025 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,105 at $0.00 | filing |
| 25 Jun 2025filed 27 Jun 2025 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —16,025 at $0.00 | filing |
| 5 Mar 2025filed 7 Mar 2025 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code A | —10,620 at $0.00 | filing |
| 5 Mar 2025filed 7 Mar 2025 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code A | —10,620 at $0.00 | filing |
| 5 Mar 2025filed 7 Mar 2025 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | —9,103 at $0.00 | filing |
| 5 Jul 2024filed 9 Jul 2024 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code A | —18,430 at $0.00 | filing |
| 5 Jul 2024filed 9 Jul 2024 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code A | —18,430 at $0.00 | filing |
| 5 Jul 2024filed 9 Jul 2024 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | —36,860 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | ARVN Arvinasoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,070 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | ARVN ArvinasBiotechnology | SEC FORM 4 Code A | —5,899 at $0.00 | filing |
| 1 May 2024filed 2 May 2024 | Exact Sciences | SEC FORM 4 Sold | $8,180136 at $60.15 | filing |
News
No headline names them, or the companies they trade most, lately.